AB-CHMINACA

Description

AB-CHMINACA

AB-CHMINACA is an indazole-based synthetic cannabinoid (CB) with 10-fold higher affinity relating to the main CB1 receptor (Ki = 0.9 nM) in contrast to JWH 018 .

AB-FUBINACA was initially synthesized, Inc. as an effective powerful CB1 receptor modulator for possible therapeutic usage, however not too long ago had been discovered together with AB-PINACA in prohibited herbal products.

AB-CHMINACA is structurally relevant to AB-FUBINACA which includes a cyclohexyl group replaced for the 4-fluorophenyl group. The physical and toxicological attributes associated with the substance haven’t been identified. The product was created for research and forensic purposes.

This fine research chemical in our laboratory. We can ensure you that when you order from us you will get a high purity research chemical for your research purspose.

This research chemical is not intended for human consumption. This cannabinoid ship direct from our lab to any country in the world.

Dosage
Presumes no tolerance

Threshold < 1 mg Light 1 – 2 mg

Common 1 – 3 mg

Strong 4 – 5 mg

Heavy > 5 mg

Duration
Total 1 – 2 hours
Onset 0 – 20 minutes
Peak 30 – 60 minutes
Offset 10 – 20 minutes
Afterglow 15 – 30 minutes

AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB₁ receptor and CB₂ receptor and fully substitutes for Δ⁹-THC in rat discrimination studies, while being 16x more potent

Research Chemicals always takes into consideration preferences of clients, wishing get in time the ordered product to the specified by them address or destination. We do online pharmacy business by the way of wholesale and drop-ship both. We do serve people with our fast, secure and discreet shipping of prescription medications. So we do ship prescription drugs world wide at door step of our customers with convenient and secure services. Working honestly and confidentially, we try to cooperate with business partners and buyers, for mutual profit and beneficial cooperation and possibility of real and serious development.

.               .